GlassScriptPhysician profile
Gajanan Kulkarni
NPI 1962408849
$20,920.94
in general payments reported to CMS, 2019-2025
76 companies · $4,261 in 2025
The $4,261 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,527 · 2020: $1,434 · 2021: $1,658 · 2022: $2,925 · 2023: $4,236 · 2024: $3,879 · 2025: $4,261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,890.40 |
| Education | $485.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,342.23 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $1,258.49 | 2019-2025 | Keytruda, Welireg, Lynparza |
| E.R. Squibb & Sons, L.L.C. | $1,203.54 | 2019-2025 | Opdivo, Krazati, Opdualag |
| Astrazeneca Pharmaceuticals LP | $1,058.94 | 2019-2025 | Imfinzi, Enhertu, Calquence |
| Astellas Pharma US INC | $1,008.52 | 2019-2025 | Vyloy, Padcev, Cresemba |
| Janssen Biotech, INC. | $981.19 | 2019-2025 | Darzalex, Rybrevant, Tecvayli |
| Lilly USA, LLC | $958.49 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Bayer Healthcare Pharmaceuticals INC. | $886.50 | 2019-2025 | |
| Pfizer INC. | $866.05 | 2019-2025 | |
| Incyte Corporation | $795.33 | 2019-2025 | Jakafi, Monjuvi |
| Celgene Corporation | $706.86 | 2019-2025 | Reblozyl, Opdualag |
| Seagen INC. | $704.25 | 2019-2023 | Adcetris, Tukysa, Padcev |
| Gilead Sciences, INC. | $547.93 | 2019-2025 | Trodelvy |
| Daiichi Sankyo INC. | $527.43 | 2020-2025 | Enhertu, Datroway, Injectafer |
| Genzyme Corporation | $504.72 | 2019-2025 |
Show all 76 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exelixis INC. | $479.98 | 2020-2025 | Cabometyx |
| Regeneron Healthcare Solutions, INC. | $445.94 | 2021-2025 | Libtayo |
| Array Biopharma INC | $418.19 | 2019-2025 | Braftovi, Mektovi, Lorbrena |
| Genentech USA, INC. | $406.18 | 2019-2025 | Tecentriq, Polivy, Venclexta |
| Amgen INC. | $393.51 | 2019-2023 | Kyprolis, Blincyto, Lumakras |
| Eisai INC. | $360.26 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $344.71 | 2019-2025 | Alunbrig, Fruzaqla |
| Glaxosmithkline, LLC. | $337.74 | 2020-2025 | Jemperli, Ojjaara, Zejula |
| Abbvie INC. | $323.67 | 2019-2025 | |
| Kite Pharma, INC. | $308.57 | 2021-2025 | Yescarta |
| Puma Biotechnology, INC. | $254.14 | 2019-2025 | |
| Sobi, INC | $240.45 | 2022-2025 | |
| Fujifilm Healthcare Americas Corporation | $187.87 | 2023 | Fujifilm |
| Emd Serono, INC. | $187.72 | 2019-2025 | Bavencio |
| Stemline Therapeutics INC. | $181.58 | 2023-2025 | Orserdu |
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.68 | 2019-2023 | Gilotrif |
| Pharmacyclics LLC, An Abbvie Company | $158.83 | 2019-2023 | Imbruvica |
| Mirati Therapeutics, INC. | $156.54 | 2023-2024 | Krazati |
| Alexion Pharmaceuticals, INC. | $136.54 | 2019-2025 | Ultomiris |
| Blueprint Medicines Corporation | $120.65 | 2021-2025 | Ayvakit |
| Pharmaessentia USA Corporation | $120.04 | 2024-2025 | Besremi |
| Karyopharm Therapeutics INC. | $108.03 | 2020-2024 | Xpovio |
| Jazz Pharmaceuticals INC. | $104.37 | 2021-2025 | |
| Kyowa Kirin, INC. | $84.50 | 2021-2025 | Poteligeo |
| Janssen Pharmaceuticals, INC | $82.50 | 2020-2024 | Darzalex |
| Genmab U.S., INC. | $75.21 | 2023-2025 | Epkinly |
| Rigel Pharmaceuticals, INC. | $75.17 | 2022-2023 | Rezlidhia, Tavalisse |
| Tersera Therapeutics LLC | $71.86 | 2019-2025 | Zoladex |
| Beigene USA, INC. | $71.51 | 2023 | Brukinsa |
| Geron Corporation | $71.29 | 2025 | Rytelo |
| Taiho Oncology, INC. | $65.32 | 2023-2025 | |
| Pharmacosmos Therapeutics INC. | $64.10 | 2023-2025 | Monoferric, Cosela |
| Adc Therapeutics America, INC. | $63.60 | 2023-2025 | |
| Deciphera Pharmaceuticals INC. | $58.74 | 2021-2025 | Qinlock, Romvimza |
| Beone Medicines USA, INC. | $56.98 | 2025 | Brukinsa, Tevimbra |
| Morphosys, US INC. | $56.95 | 2023 | Monjuvi |
| G1 Therapeutics, INC. | $54.19 | 2023 | Cosela |
| Sumitomo Pharma America, INC. | $53.92 | 2024-2025 | Orgovyx |
| Octapharma USA, INC. | $50.20 | 2020 | |
| Amag Pharmaceuticals, INC. | $40.91 | 2019-2020 | |
| Ge Healthcare | $40.09 | 2022 | |
| Servier Pharmaceuticals LLC | $39.95 | 2021-2024 | |
| Tesaro, INC. | $39.27 | 2019 | |
| Cti Biopharma Corp. | $37.95 | 2023 | Vonjo |
| Ipsen Biopharmaceuticals, INC | $33.92 | 2021-2023 | Somatuline Depot, Onivyde |
| Springworks Therapeutics, INC. | $28.77 | 2024 | Ogsiveo |
| Legend Biotech USA INC. | $28.50 | 2025 | Carvykti |
| Tg Therapeutics, INC. | $28.07 | 2021 | |
| Immunogen, INC. | $27.81 | 2024 | Elahere |
| Kadmon Pharmaceuticals LLC | $26.37 | 2019 | |
| Tempus Ai, INC | $25.96 | 2024 | Xt Cdx |
| Fennec Pharmaceuticals, INC. | $25.24 | 2024 | Pedmark |
| Epizyme, INC. | $24.99 | 2022 | |
| Syndax Pharmaceuticals, INC. | $19.82 | 2025 | |
| Apellis Pharmaceuticals, INC. | $18.73 | 2023 | Empaveli |
| Agios Pharmaceuticals, INC. | $16.55 | 2019 | |
| Partner Therapeutics, INC. | $16.31 | 2019 | |
| Myovant Sciences INC. | $14.84 | 2022 | |
| Aveo Pharmaceuticals, INC. | $14.60 | 2022 | |
| Dova Pharmaceuticals | $14.55 | 2021 | |
| Adma Biomanufacturing LLC | $4.04 | 2022 |
Drugs and devices associated with these payments
Keytruda $564Opdivo $522Reblozyl $433Cabometyx $420Libtayo $401Darzalex $399Enhertu $380Nubeqa $372Xofigo $351Verzenio $340Jaypirca $340Jakafi $330Sarclisa $328Padcev $288Imbruvica $272Trodelvy $261Monjuvi $256Braftovi $253Mektovi $248Kisqali $239Tukysa $226Adcetris $222Yescarta $209Rybrevant $193Fujifilm $188Krazati $184Orserdu $182Lorbrena $181Retevmo $168Imfinzi $158Tecvayli $154Elrexfio $149Talvey $148Bosulif $144Stivarga $137Vitrakvi $137Calquence $136Vonjo $132Vyloy $131Jemperli $129Xtandi $126Besremi $120Orgovyx $120Ojjaara $115Fabhalta $113Alunbrig $109Epkinly $109Lynparza $106Lenvima $103Welireg $103Brukinsa $101Zejula $100Venclexta $97.25Pluvicto $95.52Ibrance $90.97Elahere $84.52Datroway $80.15Xalkori $75.51Cosela $74.98Ultomiris $72.68Rytelo $71.29Poteligeo $67.90Carvykti $66.88Inqovi $65.32Lonsurf $65.32Tivdak $65.30Promacta $63.65Tecentriq $63.63Ayvakit $62.50Talzenna $59.96Scemblix $59.81Fruzaqla $58.86Xpovio $57.77Zoladex $57.15Besponsa $56.40Mekinist $50.91Piqray $47.58Inlyta $44.93Qinlock $44.21Polivy $43.57Monoferric $43.31Opdualag $41.69Erleada $41.25Tasigna $40.12Tavalisse $39.74Rezlidhia $39.74Bavencio $39.08Hympavzi $37.13Kyprolis $32.35Blincyto $32.35Zynlonta $31.17Paxlovid $29.92Ogsiveo $28.77Gazyva $27.89Columvi $27.89Lunsumio $27.89Tevimbra $27.14Xt Cdx $25.96Pedmark $25.24Cresemba $23.21
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gajanan Kulkarni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.